Global GIST Mutation Detection Kit Market Growth 2025-2031

The global GIST Mutation Detection Kit market size is predicted to grow from US$ 395 million in 2025 to US$ 561 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.

United States market for GIST Mutation Detection Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for GIST Mutation Detection Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for GIST Mutation Detection Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key GIST Mutation Detection Kit players cover EntroGen, Bio-Rad, AmoyDx, MCLAB, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “GIST Mutation Detection Kit Industry Forecast” looks at past sales and reviews total world GIST Mutation Detection Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected GIST Mutation Detection Kit sales for 2025 through 2031. With GIST Mutation Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GIST Mutation Detection Kit industry.

This Insight Report provides a comprehensive analysis of the global GIST Mutation Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GIST Mutation Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GIST Mutation Detection Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GIST Mutation Detection Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GIST Mutation Detection Kit.

This report presents a comprehensive overview, market shares, and growth opportunities of GIST Mutation Detection Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
PDGFRA
C-KIT

Segmentation by Application:
Medical
Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
EntroGen
Bio-Rad
AmoyDx
MCLAB
Thermo Fisher Scientific
LCM Genect
NimaGen
Beyotime Biotechnology
Genetron Health
Jiangsu MicroDiag Biomedicine Technology
HELIXGEN (Guangzhou)
Geneseeq
ASBACH MEDICAL PRODUCTS GMBH (AMP)
Diogene
3B BlackBio Biotech India
Panagene
Medaysis

Key Questions Addressed in this Report

What is the 10-year outlook for the global GIST Mutation Detection Kit market?

What factors are driving GIST Mutation Detection Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do GIST Mutation Detection Kit market opportunities vary by end market size?

How does GIST Mutation Detection Kit break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.